Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
CIN U24232HR2001PTC093261 Incorporated 14 March 2001 ROC Delhi HQ Panchkula, Haryana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹14.81 Cr
▼ 8% YoY
Net profit · FY 2025
₹74.87 Lakh
Net margin 5.1%
EBITDA · FY 2025
₹1.4 Cr
EBITDA margin 9.4%
Authorised capital
₹18 Lakh
Registered with MCA
Paid-up capital
₹16.23 Lakh
Issued & subscribed
Open charges
₹4.25 Cr
Satisfied ₹1.6 Cr
Company age
25 yrs
Est. 2001
Employees · EPFO
302
Provident fund records

About Acme Therapeutics (I) Private Limited

Data last updated:

Acme Therapeutics (I) Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 March 2001 and has been in existence for over 25 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232HR2001PTC093261. Its GSTIN is 10AADCA3220A1ZY (Bihar). The company holds 4 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹18 Lakh and a paid-up capital of ₹16.23 Lakh. It was formerly known as Acme Therapeutics Private Limited and Acme Pharmaceuticals Private Limited. It is led by directors including Banshidhar Kanhaiyalal and Gopal Krishna.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 1601 Tower 7A Suncity Parikrama Sector 20, Panchkula, Haryana, India – 134109.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.81 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹74.87 Lakh (net margin 5.1%) and EBITDA of ₹1.4 Cr (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 5% over five years.

The company has about 302 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹4.25 Cr and satisfied charges of ₹1.6 Cr on record. Court records list 14 cases involving the company, including 14 filed by the company; 4 cases are pending.

Acme Therapeutics (I) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0007205). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website atipl.in.

Company details

CIN U24232HR2001PTC093261
Registration Number 093261
Incorporation Date 14 March 2001
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0007205

Name history

Acme Therapeutics (I) has undergone 2 name changes throughout its history. The company was previously known as Acme Therapeutics Private Limited, and Acme Pharmaceuticals Private Limited. The current legal name is Acme Therapeutics (I) Private Limited.

Company NameStatus
Acme Therapeutics (I) Private LimitedCurrent
Acme Therapeutics Private LimitedPrevious
Acme Pharmaceuticals Private LimitedPrevious

CIN history

Acme Therapeutics (I) has one previous CIN (Corporate Identification Number): U24232MP2001PTC014592. The current CIN is U24232HR2001PTC093261, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232HR2001PTC093261Current
U24232MP2001PTC014592Previous

Recognitions & Rankings of Acme Therapeutics (I)

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MP-23-0007205

Contact details

Acme Therapeutics (I) Private Limited's registered office is in Panchkula, Haryana. Its website is atipl.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    Flat No 1601 Tower 7A Suncity Parikrama Sector 20, Panchkula, Haryana, India – 134109
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Acme Therapeutics (I) Private Limited, buy the company report.

Comprehensive company report
Acme Therapeutics (I) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Acme Therapeutics (I) is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Acme Therapeutics (I) Private Limited, buy the company report.

Financials of Acme Therapeutics (I) Private Limited

FY 2025 filings available

Acme Therapeutics (I) Private Limited reported revenue of ₹14.81 Cr (down 8% YoY) for FY 2025.

Revenue · FY 2025
₹14.81 Cr ▼ 8%
Net profit · FY 2025
₹74.87 Lakh margin 5.1%
EBITDA · FY 2025
₹1.4 Cr margin 9.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 2%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 8%
5 years · compounded
▲ 4%

Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.4 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹74.87 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.4%
Net Profit Margin5.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Acme Therapeutics (I) Private Limited, buy the company report.

Board of directors of Acme Therapeutics (I) Private Limited

Acme Therapeutics (I) has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Banshidhar KanhaiyalalDirector14 Mar 200125 Years 8 MonthsCurrent
Gopal KrishnaDirector01 May 200224 Years 6 MonthsCurrent
Sanjay KumarDirector21 Oct 20197 Years 0 MonthsCurrent

Peer comparison

Acme Therapeutics (I) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Intag Remedies Private Limited₹14.94 Cr (FY 2025)7.0%Guwahati, Assam, India
Acme Therapeutics (I) Private Limitedthis company₹14.81 Cr (FY 2025)₹74.87 Lakh5.1%-8.0%Panchkula, Haryana, India
Aashirwad Medicos Private Limited₹14.8 Cr (FY 2022)41.0%Delhi, India
Neoastra Drugs Private Limited₹14.71 Cr (FY 2025)39.0%Sarai Rohilla, Delhi, India

To see the full peer comparison of Acme Therapeutics (I) Private Limited, buy the company report.

Auditor

Acme Therapeutics (I) Private Limited is audited by N.K.DAFRIA & CO. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
N.K.DAFRIA & CO.FY 2022005550C

Shareholding

The shareholding of Acme Therapeutics (I) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Acme Therapeutics (I) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.25 Cr
Satisfied charges
₹1.6 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹2.75 Cr
Others₹1.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jan 2025101049295Hdfc Bank Limited₹2.75 CrOpen
13 Feb 2024100875794Others₹1.5 CrOpen
20 Mar 2020100341247Others₹83.25 LakhSatisfied
10 Dec 201510615973Kotak Mahindra Bank Limited₹42 LakhSatisfied
03 Jun 200490209598Punjab National Bank₹35 LakhSatisfied

To see the full charge records of Acme Therapeutics (I) Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

Acme Therapeutics (I) Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 155 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 9)

SupplierAmount dueDue sinceReported on
Akpash Pharmaceuticals Private Limited
an individual supplier
an individual supplier
Sellwell Pharmaceuticals Limited
Riemann Labs Private Limited

To see the full MSME payment records of Acme Therapeutics (I) Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Acme Therapeutics (I) has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
10AADCA3220A1ZYBiharActive01 Jul 2017
23AADCA3220A1ZRMadhya PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Acme Therapeutics (I) Private Limited, buy the company report.

Recent activity

Acme Therapeutics (I) Private Limited has 7 board changes on record since 2001: 3 appointments and 4 cessations. The latest: Sanjay Kumar was appointed as Director on 21 Oct 2019.

Charges
A charge registered on 20 Mar 2020 via Charge ID 100341247 with Others was fully satisfied on 19 Nov 2025.
AGM
Acme Therapeutics (I) Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Acme Therapeutics (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 275.00 Lakh with Charge ID 101049295 was registered on 27 Jan 2025.
Charges
A charge with Others amounted to Rs. 150.00 Lakh with Charge ID 100875794 was registered on 13 Feb 2024.
Charges
A charge with Others amounted to Rs. 83.25 Lakh with Charge ID 100341247 was registered on 20 Mar 2020.
Charges
A charge registered on 10 Dec 2015 via Charge ID 10615973 with Kotak Mahindra Bank Limited was fully satisfied on 16 Mar 2020.
Appointed
Sanjay Kumar was appointed as Director.
Ceased
Binod Kumar Agarwal ceased to be Director.
Charges
A charge with Kotak Mahindra Bank Limited amounted to Rs. 42.00 Lakh with Charge ID 10615973 was registered on 10 Dec 2015.
Charges
A charge registered on 03 Jun 2004 via Charge ID 90209598 with Punjab National Bank was fully satisfied on 18 Dec 2012.
Ceased
Rajesh Kumar Jain ceased to be Director.

7 earlier events are in the company report.

Frequently asked questions

Acme Therapeutics (I) is an active private limited company based in Panchkula, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 March 2001 (25+ years old) and is registered under CIN U24232HR2001PTC093261.

Acme Therapeutics (I) has 3 current directors:

The latest financial statements of Acme Therapeutics (I) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Acme Therapeutics (I) is 10AADCA3220A1ZY, registered in Bihar. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 23AADCA3220A1ZR (Madhya Pradesh).

The CIN (Corporate Identification Number) of Acme Therapeutics (I) is U24232HR2001PTC093261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Acme Therapeutics (I) has 14 court cases on record: 14 filed by the company. 4 are pending. Most are in the high courts.

Acme Therapeutics (I) was incorporated on 14 March 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Acme Therapeutics (I) by revenue are Intag Remedies Private Limited, Aashirwad Medicos Private Limited, Neoastra Drugs Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Sanjay Kumar was appointed as Director on 21 Oct 2019. Binod Kumar Agarwal ceased to be Director on 19 Oct 2019. Rajesh Kumar Jain ceased to be Director on 23 Mar 2009. Acme Therapeutics (I) has 7 board changes on record in total.

Yes, Acme Therapeutics (I) is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0007205).

Acme Therapeutics (I) has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 155 overdue payments to 9 micro and small suppliers. The latest return was filed on 31 Oct 2019.

Acme Therapeutics (I) can be reached through the website atipl.in. Its registered office is in Panchkula, Haryana, India.